RecruitingNCT06595134

AI-POD Clinical Validation Study for Obese Patients

AI for the Prediction of Obesity-Related Vascular Diseases - Validation Study


Sponsor

University Hospital, Bonn

Enrollment

1,200 participants

Start Date

Jul 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The study is aimed at patients who suffer from severe obesity and receive a computerised tomography (CT) scan of the heart. A total of 1200 patients across Europe are to take part in the study. It is a multi-centre, controlled, open, randomised study. As part of the study, a citizen app will be installed on a smartphone for randomly selected study participants. A fitness tracker will also be issued so that certain parameters, such as heart rate and daily number of steps, can be recorded.


Eligibility

Min Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Non Interventional for people with acute cardiovascular disease. The study is currently recruiting participants at 6 locations. People eligible for this study include aged 45 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNon Interventional

Screening (Day -7 to Day -1) Visit 1 (Day 0) Visit 2 (Month 3 +/- 7 days) Visit 3 (Month 6 +/- 7 days) Visit 4 (Month 12 +/- 7 days) Visit 5 (Month 24 +/- 7 days) Visit 6 (Month 60 +/- 30 days; end of study)


Locations(6)

Medical University Vienna

Vienna, Austria

University Hospital Leuven

Leuven, Belgium

University Hospital Pilsen

Pilsen, Czechia

University Hospital Bonn

Bonn, North Rhine-Westphalia, Germany

University Hospital Mannheim

Mannheim, Germany

University Hospital Zürich

Zurich, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06595134


Related Trials